Loading
Latest filing published 28 Jun 2024 for Oncopeptides AB.
No signal scores available.
Not enough history yet: 0 closed purchases, at least 2 are needed.
Ulf Jungnelius is a declared insider of Oncopeptides AB, with filings sourced from Finansinspektionen. In total, 3 filings cover trades dated from 28 February 2017 to 28 June 2024.
The open-market record is one-sided, with 1 purchase worth €38k and not one sale. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Other entries cover 2 share grants.
The newest entry dates from 28 June 2024: a share grant, in Oncopeptides AB. The last purchase on record was published on 7 December 2018, which is 2,879 days ago. Publication is fast: at least half of the trades appear on Finansinspektionen on the same day. The regulation allows three business days to notify a trade (MAR article 19). This summary is built from Finansinspektionen disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
3 of 3 declarations